CPESN® Michigan luminary Austin Brown reminds network leaders to look in their backyards for unexpected payer opportunities with local and regional agencies.

CPESN® Pennsylvania pharmacists will provide onsite vaccine clinic services at community outreach events held by a payer partner under an expansion of a regional Medicaid MCO program.

CPESN® North Carolina Luminary Jessi Stout says involving a pharmacy student helped make recruitment for an asthma medication study fast and easy for her Table Rock Pharmacy in Morganton, NC. The 10 participating network pharmacies met the RxE2 program goal of qualifying 32 patients for referral to the study sponsor.

Through a national payer program with Genemarkers, CPESN® pharmacies are paid a flat fee to collect patient DNA samples for testing and review results with patients. The personalized medicine approach can indicate how a patient might respond to a particular treatment or which medication may work best for an individual.

Medicaid MCO coverage of adherence packaging and delivery through CPESN® Nebraska has allowed Elmwood Pharmacy to expand the service. Pharmacist Crystal Pfeifer says that's a plus for patients and for the pharmacy.

Clinical Screening for Major Depression Disorder treatment study proved a good opportunity for pharmacies in the St. Louis, MO metro area to boost patient engagement and pharmacy revenue. Tyler Taylor CPESN Missouri regional facilitator, said the RxE2 program paid pharmacies for all steps regardless of outcome, saying that's "... very helpful in a world where we don't get paid for our work very often."

Expansion of a Medicaid MCO program allows CPESN® Pennsylvania pharmacist to add diabetes disease management to services they provide to Medicaid patients. Additionally, they will now be paid for Social Determinants of Health screenings and referrals.

Laura Rhodes, CPESN USA Regional PPP Lead, describes how quality performance by CPESN® Florida pharmacies in a 2022 Medicaid adherence program has led to renewal in that state with opportunities for nearly three times as many pharmacies, and expansion to Texas where almost 90 CPESN pharmacies will be able to participate. The two networks trained together last week, preparing for the renewal and rollout in Texas.

Helping Medicaid patients diagnosed with diabetes or hypertension control their blood pressure or lower their HbA1c is the focus goal of a broad statewide managed Medicaid program available to the nearly 200 CPESN® Pennsylvania pharmacies across the state. Early patient outcomes include significantly lowered HbA1C levels and impactful referrals to other community providers based on social determinants of health surveys.

Brianna Chesser, a pharmacist with Best Value Ridglea Pharmacy in Fort Worth, shares examples of how CPESN® Texas pharmacies are helping to improve the health of diabetes and CVD patients enrolled in a managed Medicaid program.